Business
PURE Bioscience to Present at 2017 SeeThru Equity Investor Conference
PURE Bioscience to Present at 2017 SeeThru Equity Investor Conference.
About this update from Pure Bioscience
[{"type":"text","content":"\n \n PURE Bioscience, Inc. (OTCQB: \n PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) \n antimicrobial, today announced that the Company will present at the 2017 \n SeeThru Equity Investor Conference at 11am EDT on September 27, 2017 at \n the Grand Hyatt Hotel, New York.\n \n \n Hank \n R. Lambert, CEO of PURE, will provide business updates on the \n commercialization of the Company’s two food safety antimicrobial \n products to combat foodborne illness:\n \n \n \n PURE® \n Hard Surface disinfectant:\n\n \n \n Sales to restaurant chains (including Chipotle Mexican Grill), and \n expanding use with 40+ national food processors/manufacturers\n \n \n Newly developed sanitization solution for food transportation \n vehicles\n \n \n \n \n PURE \n Control® (FDA/USDA approved direct food contact processing aid):\n\n \n \n Sales to fresh produce processors; sales and marketing to raw \n poultry parts processors\n \n \n Progress update of USDA in-plant trials for approval for raw \n poultry OLR whole bird processing\n \n \n Est. combined $650M+ US market opportunity for produce and poultry \n processing aids\n \n \n \n \n \n SDC test results demonstrate materially significant reduction in Salmonella, \n Listeria and E. coli contamination in fresh produce; and \n dramatic reduction of Salmonella contamination in raw poultry.\n \n \n The presentation will be webcast live with slides (and available for \n replay) and can be accessed at: https://www.purebio.com/investors/events-presentations/.\n \n \n About SeeThru Equity\n \n \n Since its founding in 2011, SeeThru Equity has been committed to its \n core mission: providing impactful, high quality research on \n underfollowed smallcap and microcap equities. SeeThru Equity has \n pioneered an innovative business model for equity research that is not \n paid for and is unbiased. SeeThru Equity is the host of acclaimed \n investor conferences that are the ultimate event for publicly traded \n companies with market capitalizations less than $1 billion. SeeThru \n Equity is approved to contribute its research reports and estimates to \n Thomson One Analytics (First Call), the leading estimates platform on \n Wall Street, as well as Capital IQ and FactSet.\n \n \n About PURE Bioscience, Inc.\n \n \n PURE Bioscience, Inc. is focused on developing and ...